Lymph Node Lesions |
No. |
Percentage |
Tuberculous
lymphadenitis |
117 |
68.8 |
Reactive
lymphadenitis |
41 |
24.1 |
Metastatic deposits |
3 |
1.7 |
Non Hodgkin’s Lymphoma |
1 |
0.5 |
Benign Cystic Disease |
2 |
1.1 |
Inconclusive
Aspirates |
6 |
3.5 |
Site of lymphadenopathy |
Percentage of cases |
Superficial cervical lymph nodes |
38% |
Supraclavicular lymph nodes |
26% |
Axillary lymph nodes |
15% |
Inguinal lymph nodes |
5% |
Generalized Lymphadenopathy |
16% |
Group |
Total
No of Cases |
Total
No. of ZN Positive Cases |
Group I |
40 (34.1) |
13 (32.5%) |
Group II |
39 (33.3%) |
25 (64.1%) |
Group III |
7 (5.9%) |
5 (71.4%) |
Group IV |
31 (26.4%) |
21(67.7%) |
Groups |
ZN Negative Cases |
Culture Attempted |
No. of Positive
Cultures |
Group I |
27 |
20 |
10% |
Group II |
13 |
9 |
55.5% |
Group III |
2 |
2 |
0 |
Group IV |
11 |
9 |
33.3% |
Groups |
No. of cases |
ZN Positive Cases |
Group I |
6 |
50% |
Group II |
3 |
100% |
Group III |
1 |
100% |
Group IV |
6 |
66.6% |